Company / EPS (Diluted)
UTAH MEDICAL PRODUCTS INC EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$4.57
FY2025
5-year range
$0.84 / $4.57
FY2021-FY2025
Trend
+1.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has increased for 3 consecutive years, from $0.84 in FY2022 to $4.57 in FY2025.
Based on SEC 10-K filings.
4.57 in FY2025 with a 5-year CAGR of -1.6%.
Improved from $4.04 to $4.57 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +75.9%
- 5-Year CAGR
- -1.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- UTAH MEDICAL PRODUCTS INC's eps (diluted) has grown for 3 consecutive years.
- In FY2025, eps (diluted) increased 1.1% year-over-year.
- Peak eps (diluted) was recorded in FY2020.
- Lowest eps (diluted) in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 16.69 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.57 | +1.1% |
| FY2024 | $4.52 | +11.9% |
| FY2023 | $4.04 | +381.0% |
| FY2022 | $0.84 | -78.7% |
| FY2021 | $3.94 | -20.4% |
| FY2020 | $4.95 | +117.1% |
| FY2019 | $2.28 | -29.2% |
| FY2018 | $3.22 | +2.5% |
| FY2017 | $3.14 | +4.0% |
| FY2016 | $3.02 | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026